Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12759]

Treatment guidance for lung cancer patients during the COVID-19 pandemic

Treatment guidance for lung cancer patients during the COVID-19 pandemic

Researchers develop model to predict prostate cancer aggressiveness

Researchers develop model to predict prostate cancer aggressiveness

Researchers study radiation resistance in brain cancer cells

Researchers study radiation resistance in brain cancer cells

Simple text reminders do not improve breast cancer hormone therapy adherence

Simple text reminders do not improve breast cancer hormone therapy adherence

Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer

Combination of chemo and immunotherapy is shown to work against metastatic bladder cancer

ASCO 2020: Trial confirms durable and long-term survival benefit for nivolumab plus ipilimumab over chemotherapy in metastatic first-line non-small cell lung cancer patients

ASCO 2020: Trial confirms durable and long-term survival benefit for nivolumab plus ipilimumab over chemotherapy...

Trial validates a less intense treatment for HPV positive throat cancer

Trial validates a less intense treatment for HPV positive throat cancer

A new tool to predict delays in post-surgical radiotherapy for head and neck cancer

A new tool to predict delays in post-surgical radiotherapy for head and neck cancer

ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration-resistant prostate cancer

ASCO 2020: Apalutamide significantly improved overall survival in patients with non-metastatic castration...

ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patients with relapsed ovarian cancer and BRCA mutation

ASCO 2020: Maintenance therapy With PARP inhibitor olaparib extends survival by over 1 year in patients with...

More from ecancer